IRIS
CICERI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 24.221
EU - Europa 23.846
NA - Nord America 19.301
SA - Sud America 6.051
Continente sconosciuto - Info sul continente non disponibili 1.595
AF - Africa 519
OC - Oceania 59
AN - Antartide 1
Totale 75.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.171
RU - Federazione Russa 13.235
SG - Singapore 9.162
CN - Cina 6.833
BR - Brasile 4.913
IT - Italia 3.619
HK - Hong Kong 2.947
VN - Vietnam 2.301
SE - Svezia 2.293
FR - Francia 1.172
BD - Bangladesh 929
DE - Germania 869
GB - Regno Unito 604
CA - Canada 510
IN - India 488
AR - Argentina 435
FI - Finlandia 330
NL - Olanda 327
RO - Romania 282
MX - Messico 265
AT - Austria 255
JP - Giappone 227
EC - Ecuador 206
ID - Indonesia 202
ZA - Sudafrica 190
TR - Turchia 175
PL - Polonia 172
ES - Italia 169
IQ - Iraq 166
IE - Irlanda 143
CO - Colombia 127
PY - Paraguay 100
PK - Pakistan 90
VE - Venezuela 82
CL - Cile 79
UA - Ucraina 76
SA - Arabia Saudita 72
MY - Malesia 71
JM - Giamaica 69
MA - Marocco 66
UZ - Uzbekistan 62
LT - Lituania 61
EG - Egitto 57
AE - Emirati Arabi Uniti 56
PH - Filippine 54
CR - Costa Rica 50
DZ - Algeria 49
AU - Australia 48
TN - Tunisia 47
UY - Uruguay 46
NP - Nepal 42
PE - Perù 41
TT - Trinidad e Tobago 39
IL - Israele 36
IR - Iran 35
BE - Belgio 33
HN - Honduras 32
KE - Kenya 32
KR - Corea 32
JO - Giordania 31
DO - Repubblica Dominicana 27
AZ - Azerbaigian 26
KZ - Kazakistan 25
CH - Svizzera 23
SV - El Salvador 23
TH - Thailandia 23
LB - Libano 21
NI - Nicaragua 21
GT - Guatemala 20
CZ - Repubblica Ceca 19
AL - Albania 18
ET - Etiopia 17
PT - Portogallo 17
BY - Bielorussia 16
MD - Moldavia 16
TW - Taiwan 16
BO - Bolivia 15
PA - Panama 15
PR - Porto Rico 13
DK - Danimarca 12
GR - Grecia 11
OM - Oman 11
SY - Repubblica araba siriana 11
BA - Bosnia-Erzegovina 10
BB - Barbados 10
BG - Bulgaria 10
PS - Palestinian Territory 10
BH - Bahrain 9
CI - Costa d'Avorio 9
HR - Croazia 9
KW - Kuwait 9
HU - Ungheria 8
NG - Nigeria 8
NZ - Nuova Zelanda 8
AO - Angola 7
BS - Bahamas 7
BW - Botswana 7
CY - Cipro 7
GE - Georgia 7
NO - Norvegia 7
Totale 73.863
Salva come PNG Salva come JPEG
Città #
Singapore 4.079
Hong Kong 2.904
Moscow 2.899
Ashburn 2.365
San Jose 2.300
Dallas 2.060
Shanghai 1.342
Council Bluffs 1.225
Hefei 1.099
Lauterbourg 947
Milan 878
Beijing 824
Ho Chi Minh City 814
Lawrence 812
Princeton 811
New York 804
Santa Clara 525
Hanoi 492
São Paulo 465
Los Angeles 460
Rome 309
Nuremberg 252
Boardman 235
Munich 176
Orem 167
Helsinki 163
Rio de Janeiro 157
Brooklyn 150
Tokyo 150
Warsaw 143
London 139
Montreal 133
Dublin 132
Phoenix 131
Denver 129
Chennai 123
Guangzhou 122
Chicago 121
Vienna 120
Washington 119
Belo Horizonte 110
Da Nang 110
Atlanta 108
Johannesburg 108
Seattle 107
Boston 106
Toronto 104
Stockholm 101
Haiphong 98
Mexico City 98
Cesano Boscone 96
Manchester 96
Brescia 95
Poplar 93
Frankfurt am Main 91
Lappeenranta 88
Curitiba 83
Brasília 82
Amsterdam 79
Buffalo 78
Houston 78
Ankara 76
Guayaquil 76
Naples 76
Bologna 75
Quito 72
The Dalles 72
Turku 71
Campinas 69
Pune 69
Turin 63
Baghdad 62
Castelseprio 61
Porto Alegre 59
Hangzhou 57
Salvador 57
Tashkent 56
Columbus 55
Tianjin 55
Biên Hòa 53
Hải Dương 53
Philadelphia 53
Mumbai 52
Dhaka 48
Shenzhen 47
Genoa 45
San Francisco 45
Florence 44
Goiânia 42
Guarulhos 42
Santo André 41
Buenos Aires 39
Jakarta 39
Kuala Lumpur 39
San José 39
Kingston 38
Montevideo 38
Thái Bình 36
Bergamo 35
Changsha 35
Totale 35.369
Salva come PNG Salva come JPEG
Nome #
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 432
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 390
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 250
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations 242
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 228
Loss of mismatched HLA in leukemia after stem-cell transplantation 219
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 216
Use of HSV-TK transduced donor lymphocytes in the context of allogeneic bone marrow transplantation: A paradigm of current applications and limitations in gene therapy 213
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 212
Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL) 195
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 185
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 184
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 180
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 179
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 177
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 177
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 176
Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation 175
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 175
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 173
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 173
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 170
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 169
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 168
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 165
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 163
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 162
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 161
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 160
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 160
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 156
Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy 154
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 154
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 153
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 153
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 153
Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients 152
Biobanking for COVID-19 research 149
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 147
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease 147
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 147
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 146
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 145
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 145
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 143
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 143
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 142
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia 141
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 141
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 140
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus 139
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 139
Long-term lineage commitment in haematopoietic stem cell gene therapy 138
Impact of Hydroxyurea to Treat Haematological Disorders on Male Fertility: Two Case Reports and a Systematic Review 138
CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature 138
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 138
A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation 136
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 134
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 134
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 134
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 133
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 132
QTc interval prolongation, inflammation, and mortality in patients with COVID-19 131
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 130
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 130
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 130
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation 129
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 129
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 129
A T cell epitope encoded by a subset HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation 129
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study 129
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 127
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 127
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 126
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 126
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 126
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 126
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 125
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 125
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study 125
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 125
Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population 124
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 124
One-year mental health outcomes in a cohort of COVID-19 survivors 124
Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases 124
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 123
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 122
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide 122
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 121
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 121
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 121
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 121
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 121
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients 120
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 120
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 120
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients 120
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 119
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party 119
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 119
Totale 15.342
Salva come PNG Salva come JPEG
Categoria #
all - tutte 468.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 468.756
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022740 0 2 8 240 55 36 65 102 57 90 27 58
2022/20234.925 1.762 862 248 92 190 567 209 334 392 76 113 80
2023/20243.456 201 226 396 356 327 626 192 273 29 137 179 514
2024/202515.337 1.666 466 332 471 479 1.263 2.157 1.450 2.454 2.073 1.176 1.350
2025/202646.296 3.275 3.470 3.226 6.716 3.357 1.293 4.345 3.161 11.765 2.324 1.669 1.695
2026/20274.299 1.878 2.421 0 0 0 0 0 0 0 0 0 0
Totale 75.593